Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MTX1 | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-08 |
mRNA | MRPL9 | CTRPv2 | pan-cancer | AAC | -0.2 | 3e-08 |
mRNA | PSMD4 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-08 |
mRNA | SCAMP3 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
mRNA | SDHB | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
mRNA | SCYL3 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
mRNA | MRPL24 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | ARNT | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | HAX1 | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
mRNA | JTB | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |